A Selank cycle, in the sense lifters use the phrase, has nothing behind it. No study in any species has compared one duration against another, tested whether time off changes anything, or examined tolerance with continued use. The closest real equivalent is something quite different: a course of treatment for anxiety inside the Russian medical system, where the compound is a registered medicine.
The vendor we point lifters to
Selank from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for lot 29-01260229 assays this vial at 12.29 mg against a 10 mg label, and reports no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 21, 2026.
Those two things get conflated constantly, and the conflation is where most of the confusion on this topic starts. One is a clinical decision about treating a diagnosed condition. The other is a schedule imported from bodybuilding culture and applied to a molecule that was never studied for anything bodybuilding cares about.
A course of treatment is not a cycle
In clinical use, treatment length is set by the condition. A course runs until symptoms improve or until it is clear the treatment is not working, it is supervised, and its duration is a judgement about a patient rather than a property of the compound. Russian clinical research in patients with anxiety disorders has reported symptom improvement over defined treatment periods, including in work comparing the peptide against benzodiazepine treatment.
Cycling in the lifting sense is a different concept entirely. It assumes a compound that accumulates a cost with continued exposure, so that a planned break serves a physiological purpose: recovery of a suppressed system, reduced strain on an organ, resensitisation of a receptor.
There is also a supervision difference the vocabulary hides. A course of treatment includes somebody checking whether it is working and deciding when to stop. A cycle, as the word is used online, has a start date and an end date chosen in advance by the person taking it, which is a schedule rather than a decision.
Nobody has shown that this peptide accumulates any such cost. Nobody has shown that it does not. What can be said is that the reasoning behind cycling was developed for a different class of drugs, and moving the vocabulary across does not move the physiology with it.
What a Selank cycle would even be aiming at
Worth asking directly, because the answer exposes the problem. A cycle is organised around an outcome. Steroid users cycle around gaining tissue and recovering an axis. Someone cycling a stimulant is organising around tolerance.
The outcome studied for this compound is anxiety symptom reduction, in patients with anxiety disorders. If that were the aim, the sensible framework is a clinical one: treat while the problem exists, under supervision, and stop when it resolves. That is not cycling, it is treatment.
If the aim is body composition, there is no outcome to organise around at all. No study in any organism has measured lean mass, strength, power, body fat or muscle protein synthesis after administration of this peptide. A cycle designed around a result that has never been demonstrated is a schedule wrapped around an assumption.
The anabolic question, and why the answer is short
This site is about lean mass, so the question underneath the search deserves an unambiguous answer: there is none.
Selank has no described action on the myostatin pathway. It has no described effect on satellite cells, on muscle protein synthesis or on any anabolic signalling in any organism. No study in rats, in cell culture or in humans has used a muscle or performance outcome. There is no small positive finding being oversold here, and no negative finding to report. The measurement has never been taken.
The mechanistic work that exists points somewhere else entirely. Rat studies have reported effects on brain serotonin metabolism and on brain derived neurotrophic factor expression. Laboratory work in human plasma has described slowed breakdown of endogenous enkephalins. That is a neurochemical profile consistent with an anxiolytic, and it is nothing to do with muscle.
It is worth naming why the anabolic question keeps getting attached to compounds like this one. Peptides are sold as a single product category, so a molecule developed for psychiatry ends up in the same conversation as growth hormone secretagogues and experimental myostatin inhibitors, which work by different mechanisms and have separate evidence bases. Once the category is accepted, an anabolic question feels natural to ask about any member of it. The category is a shop layout, not a pharmacological class.
Anyone selling this compound with an anabolic framing has invented the framing.
Stacking, and the catalogue effect
Cycle discussions rarely stay on one compound. The next question is what to run alongside it, and that is where category confusion does the most damage.
No interaction or combination study exists for this peptide in any species. Claims that it pairs well with a healing peptide, a secretagogue or a metabolic compound are not derived from research on those combinations, because that research has not been done. They are derived from the compounds appearing on the same page of the same shop.
There is a specific hazard here. The described mechanism is neurochemical, involving serotonin metabolism in rats and endogenous signalling peptides in laboratory work. Anyone already taking psychiatric medication would be combining an unstudied substance with a regulated one acting on overlapping systems, and no study anywhere has examined that combination.
What time on a compound would need to show
Suppose somebody wanted to answer the duration question properly. The study would run the same compound for different lengths in comparable groups, measure the outcome repeatedly rather than once, and include a group that stopped and restarted to see whether the break changed anything.
That design has not been run for this peptide, in rats or in humans. The Russian clinical literature reports outcomes over treatment courses chosen for patients, which answers a clinical question rather than a duration one. There is no published tolerance study, no withdrawal study, and no examination of what happens on stopping.
The confident schedules in circulation are therefore not simplifications of a complicated answer. They are answers to a question nobody has studied, and their precision is the tell.
Why breaks exist, compound by compound
| Class | Why a break is used | Evidence for that reason | Organism |
|---|---|---|---|
| Anabolic androgenic steroids | Recovery from suppression of endogenous production | Established, measured | Human |
| Benzodiazepines | Tolerance and dependence liability | Established, measured | Human |
| Growth hormone secretagogues | Receptor desensitisation with continuous exposure | Described, variable by compound | Human, rat |
| Selank | No established reason | No suppression, tolerance or desensitisation study exists | None |
The bottom row is not a claim that breaks are unnecessary. It is a statement that the question has never been studied, so a schedule presented with confidence is presenting confidence rather than knowledge.
Questions people ask before starting anything
How long should a Selank cycle last?
No study has compared durations in any species, so no evidence based answer exists. The clinical courses in the Russian literature were treatment decisions for patients with anxiety disorders, not schedules for healthy lifters.
Does tolerance develop with continued use?
Unknown. No tolerance or desensitisation study has been published in rats, in cells or in humans.
Does it need post cycle support of any kind?
The concept comes from compounds that suppress endogenous hormone production. Nothing of that sort has been reported for this peptide, and nothing has been studied either.
Should it be timed around a training block?
There is no basis for timing it around training. No study in any organism has examined this compound alongside exercise or measured any training related outcome.
Can it be combined with other peptides on a cycle?
No interaction or combination study exists in any species. Stacking claims about this compound are constructed from category membership on a vendor page rather than from data.
Is it anabolic in any way?
No. Nothing published in any organism describes an anabolic action, and no muscle outcome has ever been measured.
The version of this question that is actually useful
If the real problem is anxiety severe enough to disrupt sleep, appetite and training, that is a genuine problem with genuine treatments, and the ones with substantial evidence in the systems most readers can access come from a doctor rather than from a vial with a research label on it.
If the real goal is lean mass on an ageing frame, this compound is not a lever. The plausible connection people reach for, that calmer training means more consistent training and consistency protects muscle over decades, is coherent as reasoning and completely untested for this molecule. No study has followed anyone using it and measured adherence, recovery or body composition.
And whatever schedule someone settles on, outside Russia they are not taking the registered medicine. They are taking a research chemical with no marketing authorisation from the FDA, the EMA or the MHRA, whose identity, purity and quantity are attested by the seller and verified by no regulator. A precise cycle applied to an unverified substance produces the feeling of control rather than the fact of it.